scPharmaceuticals Inc. financial data

Symbol
SCPH
Location
Burlington, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q2 2025 - 07 Aug 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 594 % -12.9%
Quick Ratio 90.79 % +9.7%
Debt-to-equity 2,196 % +10.8%
Return On Equity -2,086 % -9.3%
Return On Assets -90.85 % -29%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 53,298,296 shares +6.5%
Common Stock, Shares, Outstanding 53,290,227 shares +47.5%
Entity Public Float 274,229,184 USD +2.6%
Common Stock, Value, Issued 5,000 USD +25%
Weighted Average Number of Shares Outstanding, Basic 53,719,662 shares +37.8%
Weighted Average Number of Shares Outstanding, Diluted 53,719,662 shares +37.8%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue 15,758,000 USD +1.3%
Research and Development Expense 15,424,000 USD +26.8%
Operating Income (Loss) -66,540,000 USD -10.2%
Net Income (Loss) Attributable to Parent -91,716,000 USD -51.2%
Earnings Per Share, Basic -1 USD/shares -16.7%
Earnings Per Share, Diluted -1 USD/shares -16.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 40,809,000 USD +6%
Accounts Receivable, after Allowance for Credit Loss, Current 19,409,000 USD +2.2%
Inventory, Net 14,573,000 USD -4.8%
Assets, Current 78,729,000 USD +25.7%
Property, Plant and Equipment, Net 48,000 USD +2.1%
Operating Lease, Right-of-Use Asset 1,175,000 USD -10.2%
Assets 80,255,000 USD +22.6%
Accounts Payable, Current 4,026,000 USD -24%
Employee-related Liabilities, Current 4,137,000 USD +29.5%
Accrued Liabilities, Current 16,082,000 USD +1.2%
Liabilities, Current 20,430,000 USD +58%
Operating Lease, Liability, Noncurrent 984,000 USD -16.9%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 101,571,000 USD +80.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -404,260,000 USD -29.3%
Stockholders' Equity Attributable to Parent -21,316,000 USD -3.3%
Liabilities and Equity 80,255,000 USD +22.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -17,139,000 USD +3.2%
Net Cash Provided by (Used in) Financing Activities -972,000 USD
Net Cash Provided by (Used in) Investing Activities 29,319,000 USD +3.2%
Common Stock, Shares Authorized 150,000,000 shares 0%
Common Stock, Shares, Issued 53,290,227 shares +47.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -18,111,000 USD -2.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 40,809,000 USD +6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1,385,000 USD -5.7%
Deferred Tax Assets, Valuation Allowance 94,093,000 USD +28.6%
Deferred Tax Assets, Gross 94,427,000 USD +27%
Operating Lease, Liability 1,248,000 USD -9.2%
Depreciation 17,000 USD -26.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -91,716,000 USD -51.3%
Lessee, Operating Lease, Liability, to be Paid 1,565,000 USD -14.7%
Property, Plant and Equipment, Gross 136,000 USD +14.3%
Operating Lease, Liability, Current 264,000 USD +38.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 367,000 USD +5.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 384,000 USD +12.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 317,000 USD -31.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 369,000 USD +3.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits 1,383,000 USD +11.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 249,000 USD -32.2%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 5,325,000 USD -5.4%
Interest Expense 6,121,000 USD -27%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%